Devan Shah

Chief Executive Officer at RNAV8 BIO.

Raised on RNAV8 BIO filings

$2M

of $3M offered across 1 Form D filing

Company

Biotech · Laguna Niguel, CA

Machine learning design of mRNA for higher expression

Machine learning design of mRNA for higher expression

RNAV8 BIO Form D filings
Filed	Security	Sold of offered	Filing
Mar 17, 2025	Option to acquire	$2M/ $3M	Form D/A